Skip to main content

Find Clinical Trials

Home
Conditions
Thrombophilia

Clinical trial condition

Thrombophilia

Explore clinical trials studying Thrombophilia. Study availability and eligibility vary by location and protocol.

80 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Thrombophilia trial results

Completed

The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)

NCT00937131

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations: St Bartholomew's Hospital London, United Kingdom

St Thomas Hosptial London, United Kingdom

University College London Hospitals London, United Kingdom

View Trial Details

Completed

Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)

NCT00713193

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +16 more
Locations: Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Blood Management During ECMO for Cardiac Support

NCT03714048

Conditions: Arrhythmias, Cardiac, Blood Coagulation Disorders, Blood Transfusion, +26 more
Locations: St Vincent's Hospital Sydney, New South Wales, Australia

View Trial Details

Completed

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura

NCT02553317

Conditions: Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations: Investigator Site Birmingham, Alabama, United States

Investigator Site Los Angeles, California, United States

Investigator Site Atlanta, Georgia, United States

Investigator Site Boston, Massachusetts, United States

View all 101 locations

View Trial Details

Completed

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

NCT01151423

Conditions: Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations: Investigator Site Los Angeles, California, United States

Investigator Site Washington D.C., District of Columbia, United States

Investigator Site Atlanta, Georgia, United States

Investigator Site St Louis, Missouri, United States

View all 51 locations

View Trial Details

Completed

Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients

NCT04873349

Conditions: Blood Coagulation Disorders, Bronchial Diseases, Bronchitis, +28 more
Locations: Shimaa Abdelgawad Al Fayyum, Egypt

View Trial Details

Completed

Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

NCT03922308

Conditions: Acquired Thrombotic Thrombocytopenic Purpura (aTTP), Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations: The University of Alabama at Birmingham Birmingham, Alabama, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

University of Minnesota Minneapolis, Minnesota, United States

University Hospitals Cleveland Medical Center Cleveland, Ohio, United States

View all 24 locations

View Trial Details

Completed

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

NCT04723602

Conditions: Acquired Immunodeficiency Syndrome, Acquired angioedema, Angioedema, +64 more
Locations: Oklahoma Blood Institute (OBI) Oklahoma City, Oklahoma, United States

View Trial Details

Completed

Prospective Investigation of Antithrombin III Deficiency in Adult Patients With ECMO

NCT04879550

Conditions: Antithrombin III Deficiency, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +7 more
Locations: Istanbul Dr.Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital Istanbul, Turkey (Türkiye)

View Trial Details

Completed

Coagulation Changes Associated With COVID-19 Infection

NCT04460664

Conditions: Blood Coagulation Disorders, COVID, COVID-19, +20 more
Locations: Texas Tech University Health Sciences Center El Paso El Paso, Texas, United States

View Trial Details